InsiderTrades

Form 4 for GILD Gilead Sciences

Accepted 2026-03-02 00:00:00 ET · period of report 2026-02-27 · accession 0001638643-26-000012 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
2026-03-02 2026-02-27 GILD O'Day Daniel Patrick COB, CEO, Dir A - Grant $0.00 +38.4K 652.3K +6% $0
M 2026-03-02 2026-02-27 GILD O'Day Daniel Patrick COB, CEO, Dir S - Sale $144.79 -10.0K 642.3K -2% -$1.45M

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-02-27 A A 38,396 $0.00 652,308 D — — (F1) Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on March 10, 2025. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors.
2 Common Common Stock 2026-02-27 S D 3,481 $144.04 648,827 D — — (F3) Sale prices for the transactions reported range from $143.63 to $144.59. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
3 Common Common Stock 2026-02-27 S D 6,419 $145.18 642,408 D — — (F4) Sale prices for the transactions reported range from $144.66 to $145.65. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
4 Common Common Stock 2026-02-27 S D 100 $145.71 642,308 D — —